<doc><docmeta id="113hr80ih"><bill congress="113" type="hr" number="80" version="ih"/><revision id="16" commit-time="2013-03-08T18:13:06+00:00" comitter="/users/favila.xml" doc="/docs/113hr80ih/16.xml" status="complete"><description>Edited via AKN</description></revision></docmeta><bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H99F8D3764F9A46459FCABAE3F637B71B" public-private="public">
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 80</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130103">January 3, 2013</action-date>
			<action-desc>
        <sponsor name-id="J000032">Ms. Jackson Lee</sponsor>
			 introduced the following bill; which was referred to the
			 <committee-name committee-id="HIF00">Committee on Energy and
			 Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To provide for research and education with respect to
		  triple-negative breast cancer, and for other purposes.</official-title>
	</form>
	<legis-body id="H08A1AADC82B74DDF9518B5C0B9BB5722" style="OLC">
		<section id="H1E5332D3DF744D329A7550288261C4B2" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Triple-Negative Breast Cancer Research
			 and Education Act of 2013</short-title>
        </quote>.</text>
		</section>
    <section id="HBF2A8B817FF54CF59D54B1EC63C25A2B">
      <enum>2.</enum>
      <header>Findings</header>
      <text display-inline="no-display-inline">
        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> finds as follows:</text>
			<paragraph id="HB3542156620746E3A48046224F067C7A">
        <enum>(1)</enum>
        <text>Breast cancer
			 accounts for 1 in 4 cancer diagnoses among women in this country.</text>
			</paragraph>
      <paragraph id="HB137BBA1257E4C389AB81B16520190E6">
        <enum>(2)</enum>
        <text>The survival rate
			 for breast cancer has increased to 90 percent for White women and 78 percent
			 for African-American women.</text>
			</paragraph>
      <paragraph id="H8A61E7DD09CE4613B765B5EA59247279">
        <enum>(3)</enum>
        <text>African-American
			 women are more likely to be diagnosed with larger tumors and more advanced
			 stages of breast cancer despite a lower incidence rate.</text>
			</paragraph>
      <paragraph id="H35FF91F900624F8599B9C3164818D1D2">
        <enum>(4)</enum>
        <text>Early detection
			 for breast cancer increases survival rates for breast cancer, as evidenced by a
			 5-year relative survival rate of 98 percent for breast cancers that are
			 discovered before the cancer spreads beyond the breast, compared to 23 percent
			 for stage IV breast cancers.</text>
			</paragraph>
      <paragraph id="HB5CA11B04D9E419F81103F8C2111C0D5">
        <enum>(5)</enum>
        <text>Triple-negative
			 breast cancer is a term used to describe breast cancers whose cells do not have
			 estrogen receptors and progesterone receptors, and do not have an excess of the
			 HER2 protein on their sources.</text>
			</paragraph>
      <paragraph id="H6960B7CC35AD40508A527C8D8DA1B806">
        <enum>(6)</enum>
        <text>It is estimated
			 that between 10 and 20 percent of female breast cancer patients are diagnosed
			 with triple-negative breast cancer, and studies indicate the prevalence of
			 triple-negative breast cancer is much higher.</text>
			</paragraph>
      <paragraph id="H74A81F9497614F2B84DCC1A737B99775">
        <enum>(7)</enum>
        <text>Triple-negative
			 breast cancer most commonly affects African-American women, followed by
			 Hispanic women.</text>
			</paragraph>
      <paragraph id="H4CB5D84D469F453DB0DEF3667E473E17">
        <enum>(8)</enum>
        <text>Triple-negative
			 breast cancer is a very aggressive form of cancer which affects women under the
			 age of 50 across all racial and socioeconomic backgrounds.</text>
			</paragraph>
      <paragraph id="H83AD472F29F84459B81727B5E72726CB">
        <enum>(9)</enum>
        <text>African-American
			 women are 3 times more likely to develop triple-negative breast cancer than
			 White women.</text>
			</paragraph>
      <paragraph id="HDD27453D9F3F4D80B20813C771E2C43D">
        <enum>(10)</enum>
        <text>Triple-negative
			 breast cancer tends to grow and spread more quickly than most other types of
			 breast cancer.</text>
			</paragraph>
      <paragraph id="HEECC47D2D43D47889E7EF30BE503AC7E">
        <enum>(11)</enum>
        <text>Like other forms
			 of breast cancer, triple-negative breast cancer is treated with surgery,
			 radiation therapy, or chemotherapy.</text>
			</paragraph>
      <paragraph commented="no" id="HCDACD976734D4BFC93C391CD05525FE3">
        <enum>(12)</enum>
        <text>Early-stage
			 detection of triple-negative breast cancer is the key to survival because the
			 tumor cells lack certain receptors, and neither hormone therapy nor drugs that
			 target these receptors are effective against these cancers; therefore, early
			 detection and education is vital.</text>
			</paragraph>
      <paragraph commented="no" id="H0FA4E91BC6634B12918EED1FC6088278">
        <enum>(13)</enum>
        <text>Current research
			 and available data do not provide adequate information on—</text>
				<subparagraph id="H3A7A5243FD224B148291540400411ECD">
          <enum>(A)</enum>
          <text>the rates of
			 prevalence and incidence of triple-negative breast cancer in African-American,
			 Hispanic, and other minority women;</text>
				</subparagraph>
        <subparagraph id="H06AA4C41F9D745A5B6EF102741F7C30C">
          <enum>(B)</enum>
          <text>he costs
			 associated with treating triple-negative breast cancer; and</text>
				</subparagraph>
        <subparagraph id="HDD27587484D24405BAB6BB9442057708">
          <enum>(C)</enum>
          <text>the methods by
			 which triple-negative breast cancer may be prevented or cured in these
			 women.</text>
				</subparagraph>
      </paragraph>
    </section>
    <section id="H867125F4FA1048F8A43238521D3C07F4">
      <enum>3.</enum>
      <header>Research with
			 respect to triple-negative breast cancer</header>
			<subsection id="H9BB75821EDBD46B59C574AF1D384A104">
        <enum>(a)</enum>
        <header>Research</header>
        <text>The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">Director of the National Institutes of Health</cato:entity-ref> (in this section referred to as
			 the <term>Director of NIH</term>) shall expand, intensify, and coordinate
			 programs for the conduct and support of research with respect to
			 triple-negative breast cancer.</text>
			</subsection>
      <subsection id="H0EC78C9C3BC94DDF9C9D88B1C0A91C2A">
        <enum>(b)</enum>
        <header>Administration</header>
        <text>The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">Director of NIH</cato:entity-ref> shall carry out this section through the appropriate
			 institutes, offices, and centers of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">National Institutes of Health</cato:entity-ref>,
			 including the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-parent-id="7529">Eunice Kennedy Shriver National Institute of Child Health and
			 Human Development</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-parent-id="7529">National Institute of Environmental Health Sciences</cato:entity-ref>, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-parent-id="7529">Office of Research on Women’s Health</cato:entity-ref>, and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-parent-id="7529">National Institute on Minority
			 Health and Health Disparities</cato:entity-ref>.</text>
			</subsection>
      <subsection id="HE3FC985131EB4EA0AC06EF364206020F">
        <enum>(c)</enum>
        <header>Coordination of
			 activities</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-parent-id="7529">Director of the Office of Research on Women’s
			 Health</cato:entity-ref> shall coordinate activities under this section among the institutes,
			 offices, and centers of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">National Institutes of Health</cato:entity-ref>.</text>
			</subsection>
      <subsection id="H422D4C6FA65E4B6ABC02F586881DC7FF">
        <enum>(d)</enum>
        <header>Authorization of
			 appropriations</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
            <cato:property name="purpose">For the purpose of carrying out <cato:entity-ref entity-type="act" value="Triple-Negative Breast Cancer Research and Education Act of 2013/s:3" proposed="true">this section</cato:entity-ref>
            </cato:property>,
			 there are authorized to be appropriated <cato:funds-and-year amount="500000" year="2014, 2015, 2016">$500,000 for each of the fiscal years
			 2014 through 2016</cato:funds-and-year>.</cato:entity>
        </text>
			</subsection>
    </section>
    <section id="H9913EE0095384FF4BB88B301E548146F">
      <enum>4.</enum>
      <header>Education and
			 dissemination of information with respect to triple-negative breast
			 cancer</header>
			<subsection id="H92E7F485286A436CAEA40A198D08665E">
        <enum>(a)</enum>
        <header>Triple-Negative
			 breast cancer public education program</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health
			 and Human Services</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease
			 Control and Prevention</cato:entity-ref>, shall develop and disseminate to the public information
			 regarding triple-negative breast cancer, including information on—</text>
				<paragraph id="H965FC7D610B4406BBB3C76D3879DCE6F">
          <enum>(1)</enum>
          <text>the incidence and
			 prevalence of triple-negative breast cancer among women;</text>
				</paragraph>
        <paragraph id="HDD49364B2E8E450389E5A14EBA48147D">
          <enum>(2)</enum>
          <text>the elevated risk
			 for minority women to develop triple-negative breast cancer; and</text>
				</paragraph>
        <paragraph id="HF387759E94304D028F5499A4A7AFC305">
          <enum>(3)</enum>
          <text>the availability,
			 as medically appropriate, of a range of treatment options for symptomatic
			 triple-negative breast cancer.</text>
				</paragraph>
      </subsection>
      <subsection id="H2FA28F9BB4A0435CAB4C99D1F334F66B">
        <enum>(b)</enum>
        <header>Dissemination of
			 information</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may disseminate information under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Triple-Negative Breast Cancer Research and Education Act of 2013/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref> directly or through arrangements with nonprofit organizations,
			 consumer groups, institutions of higher education, Federal, State, or local
			 agencies, or the media.</text>
			</subsection>
      <subsection id="H721AD74AEBAD41CD9C8D4081E52637E2">
        <enum>(c)</enum>
        <header>Authorization of
			 appropriations</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
            <cato:property name="purpose">For the purpose of carrying out <cato:entity-ref entity-type="act" value="Triple-Negative Breast Cancer Research and Education Act of 2013/s:4" proposed="true">this section</cato:entity-ref>
            </cato:property>,
			 there are authorized to be appropriated such sums as may be necessary for each
			 of the <cato:funds-and-year year="2014..2016" amount="indefinite">fiscal years 2014 through 2016</cato:funds-and-year>.</cato:entity>
        </text>
			</subsection>
    </section>
    <section id="HB9B2A1939E4945039A68DA92E20EAC9A">
      <enum>5.</enum>
      <header>Information to
			 health care providers with respect to triple-negative breast cancer</header>
			<subsection id="HC1AE5EC232104E04A7282DAFEA25E5B5">
        <enum>(a)</enum>
        <header>Dissemination of
			 information</header>
        <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of
			 Health and Human Services</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7526">Administrator of the Health
			 Resources and Services Administration</cato:entity-ref>, shall develop and disseminate to health
			 care providers information on triple-negative breast cancer for the purpose of
			 ensuring that health care providers remain informed about current information
			 on triple-negative breast cancer. Such information shall include the elevated
			 risk for minority women to develop triple-negative breast cancer and the range
			 of available options for the treatment of symptomatic triple-negative breast
			 cancer.</text>
			</subsection>
      <subsection id="HB94F99BDA68C47C9B3DF38F196956E48">
        <enum>(b)</enum>
        <header>Authorization of
			 appropriations</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
            <cato:property name="purpose">For the purpose of carrying out <cato:entity-ref entity-type="act" value="Triple-Negative Breast Cancer Research and Education Act of 2013/s:5" proposed="true">this section</cato:entity-ref>
            </cato:property>,
			 there are authorized to be appropriated such sums as may be necessary for each
			 of the <cato:funds-and-year year="2014..2018" amount="indefinite">fiscal years 2014 through 2018</cato:funds-and-year>.</cato:entity>
        </text>
			</subsection>
    </section>
    <section id="H7D3C9C3E30D54088A5D66126856225E0">
      <enum>6.</enum>
      <header>Definition</header>
      <text display-inline="no-display-inline">In this Act, the term <term>minority
			 women</term> means women who are members of a racial and ethnic minority group,
			 as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Public Health Service Act/s:1707/ss:g">section 1707(g) of the Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/300u–6/g">42 U.S.C.
			 300u–6(g)</cato:entity-ref>)</cato:entity>.</text>
		</section>
  </legis-body>
</bill></doc>